PMV Pharmaceuticals Inc

PMVP · NASDAQ

Pharmaceutical Preparation Manufacturing

PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutants. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.

Market Data

Price $1.62 -0.01 (-0.61%)

Market Cap$87M

P/E Ratio—

EPS$—

52W High$1.88

52W Low$0.81

Beta1.31

Data from Finnhub · Updated Mar 11, 2026